{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:11:01Z","timestamp":1786421461124,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-024-04923-1","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T11:01:50Z","timestamp":1727521310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of thalidomide for recurrent aphthous stomatitis: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"24","author":[{"given":"Yang","family":"Jian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianru","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"2","key":"4923_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1079-2104(96)80403-3","volume":"81","author":"AS Jonathan","year":"1996","unstructured":"Jonathan AS, Arbor DMD, Mich A. Recurrent aphthous stomatitis: an update. Oral Surg Oral Med Oral Pathol Oral Radiol. 1996;81(2):141\u20137.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"1","key":"4923_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/ajhp\/58.1.41","volume":"58","author":"RW Barrons","year":"2001","unstructured":"Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health-Syst Pharm. 2001;58(1):41\u201350.","journal-title":"Am J Health-Syst Pharm"},{"issue":"40","key":"4923_CR3","first-page":"665","volume":"111","author":"A Altenburg","year":"2014","unstructured":"Altenburg A, El-Haj N, Micheli C, Puttkammer M, Abdel-Naser MB, Zouboulis CC. The treatment of chronic recurrent oral aphthous ulcers. Dtsch Arztebl Int. 2014;111(40):665\u201373.","journal-title":"Dtsch Arztebl Int"},{"issue":"1155","key":"4923_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/postgradmedj-2020-139421","volume":"98","author":"ZH Wang","year":"2022","unstructured":"Wang ZH, Cao HB, Xiong JQ, Lu YL, Deng YX, Nan H, et al. Recent advances in the aetiology of recurrent aphthous stomatitis (RAS). Postgrad Med J. 2022;98(1155):57\u201366.","journal-title":"Postgrad Med J"},{"key":"4923_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00005-013-0261-y","volume":"62","author":"Z Slebioda","year":"2014","unstructured":"Slebioda Z, Szponar E, Kowalska A. Etiopathogenesis of recurrent aphthous stomatitis and the role of immunologic aspects: literature review. Arch Immunol Ther Exp. 2014;62:205\u201315.","journal-title":"Arch Immunol Ther Exp"},{"issue":"4","key":"4923_CR6","doi-asserted-by":"publisher","first-page":"e2021099","DOI":"10.5826\/dpc.1104a99","volume":"11","author":"M Manfredini","year":"2021","unstructured":"Manfredini M, Guida S, Giovani M, Lippolis N, Spinas E, Farnetani F, et al. Recurrent aphthous stomatitis: treatment and management. Dermatol Pract Concept. 2021;11(4):e2021099.","journal-title":"Dermatol Pract Concept"},{"issue":"5","key":"4923_CR7","first-page":"74","volume":"7","author":"B Tarakji","year":"2015","unstructured":"Tarakji B, Gazal G, Al-Maweri SA, Azzeghaiby SN, Alaizari N. Guideline for the diagnosis and treatment of recurrent Aphthous Stomatitis for Dental Practitioners. J Int Oral Health. 2015;7(5):74\u201380.","journal-title":"J Int Oral Health"},{"issue":"3","key":"4923_CR8","first-page":"314","volume":"57","author":"LJ Shi","year":"2022","unstructured":"Shi LJ, Zhou ZT. Diagnosis and management of recurrent aphthous ulcer. Chin J Stomatol. 2022;57(3):314\u20138.","journal-title":"Chin J Stomatol"},{"issue":"2","key":"4923_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/bdrc.21096","volume":"105","author":"N Vargesson","year":"2015","unstructured":"Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today. 2015;105(2):140\u201356.","journal-title":"Birth Defects Res C Embryo Today"},{"issue":"6","key":"4923_CR10","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s10067-016-3256-3","volume":"35","author":"DD Wang","year":"2016","unstructured":"Wang DD, Chen HF, Wang SY, Zou YH, Li J, Pan JP, et al. Thalidomide treatment in cutaneous lesions of systemic lupus erythematosus: a multicenter study in China. Clin Rheumatol. 2016;35(6):1521\u20137.","journal-title":"Clin Rheumatol"},{"key":"4923_CR11","doi-asserted-by":"publisher","first-page":"814302","DOI":"10.3389\/fphar.2021.814302","volume":"12","author":"YF Lu","year":"2022","unstructured":"Lu YF, Wei ZB, Yang GH, Lai YR, Liu RR. Investigating the efficacy and safety of Thalidomide for treating patients with \u03b2-Thalassemia: a Meta-analysis. Front Pharmacol. 2022;12:814302.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4923_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/art.10396","volume":"47","author":"F Huang","year":"2002","unstructured":"Huang F, Gu JR, Zhao W, Zhu J, Zhang JL, Yu DT. One-year open-label trial of thalidomide in ankylosing spondylitis. Arthritis Rheum. 2002;47(3):249\u201354.","journal-title":"Arthritis Rheum"},{"key":"4923_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.critrevonc.2017.03.014","volume":"113","author":"PM Aguiar","year":"2017","unstructured":"Aguiar PM, de Mendon\u00e7a Lima T, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Crit Rev Oncol Hematol. 2017;113:195\u2013212.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"4923_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/clinids\/20.2.250","volume":"20","author":"DL Paterson","year":"1995","unstructured":"Paterson DL, Georghiou PR, Allworth AM, Kemp RJ. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection. Clin Infect Dis. 1995;20(2):250\u20134.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4923_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.oooo.2020.06.009","volume":"130","author":"MC Harte","year":"2020","unstructured":"Harte MC, Saunsbury TA, Hodgson TA. Thalidomide use in the management of oromucosal disease: a 10-year review of safety and efficacy in 12 patients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130(4):398\u2013401.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6","key":"4923_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","volume":"128","author":"V Hamuryudan","year":"1998","unstructured":"Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, et al. Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;128(6):443\u201350.","journal-title":"Ann Intern Med"},{"issue":"5","key":"4923_CR17","doi-asserted-by":"publisher","first-page":"814","DOI":"10.4103\/1673-5374.156988","volume":"10","author":"HX Xue","year":"2015","unstructured":"Xue HX, Fu WY, Cui HD, Yang LL, Zhang N, Zhao LJ. High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis. Neural Regen Res. 2015;10(5):814\u20138.","journal-title":"Neural Regen Res"},{"issue":"8","key":"4923_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1055\/s-0032-1328890","volume":"38","author":"TJ Moore","year":"2012","unstructured":"Moore TJ, Bennett CL. Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on adverse reactions (SONAR). Semin Thromb Hemost. 2012;38(8):905\u20137.","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"4923_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/MD.0b013e3181dfca14","volume":"89","author":"M Hello","year":"2010","unstructured":"Hello M, Barbarot S, Bastuji-Garin S, Revuz J, Chosidow O. Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis. Med (Baltim). 2010;89(3):176\u201382.","journal-title":"Med (Baltim)"},{"key":"4923_CR20","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"4923_CR21","doi-asserted-by":"crossref","unstructured":"Higgins J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition. Chichester (UK): John Wiley & Sons; 2019.","DOI":"10.1002\/9781119536604"},{"issue":"1","key":"4923_CR22","first-page":"18","volume":"22","author":"H Chen","year":"2014","unstructured":"Chen H, He J, Zhou SL, Zhang EP. Comparison of effect on major recurrent aphtha with different methods of treatment. J Dent Prevent Treat. 2014;22(1):18\u201321.","journal-title":"J Dent Prevent Treat"},{"issue":"1","key":"4923_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/jop.13259","volume":"51","author":"YW Deng","year":"2022","unstructured":"Deng YW, Wei W, Wang YF, Pan L, Du GH, Yao H, et al. A randomized controlled clinical trial on dose optimization of thalidomide in maintenance treatment for recurrent aphthous stomatitis. J Oral Pathol Med. 2022;51(1):106\u201312.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"4923_CR24","first-page":"326","volume":"21","author":"Q Gao","year":"2007","unstructured":"Gao Q, Chen HZ, Li HB, Jia ZY. The clinical effects of thalidomide in the treatment of Major Aphthous Ulcer. J Mod Stomatol. 2007;21(3):326.","journal-title":"J Mod Stomatol"},{"key":"4923_CR25","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199705223362103","volume":"336","author":"JM Jacobson","year":"1997","unstructured":"Jacobson JM, Greenspan JS, Spritzler J, Ketter N, Fahey JL, Jackson JB. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. N Engl J Med. 1997;336:1487\u201393.","journal-title":"N Engl J Med"},{"key":"4923_CR26","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1001\/archderm.1990.01670310085012","volume":"126","author":"J Revuz","year":"1990","unstructured":"Revuz J, Guillaume J-C, Janier M, Hans P, Marchand C, Souteyrand P. Crossover study of Thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol. 1990;126:923\u20137.","journal-title":"Arch Dermatol"},{"issue":"16","key":"4923_CR27","first-page":"83","volume":"29","author":"YH Lin","year":"2020","unstructured":"Lin YH. Clinical study of thalidomide in the treatment of recurrent oral ulcer. J Med Aesthet Cosmetol. 2020;29(16):83.","journal-title":"J Med Aesthet Cosmetol"},{"issue":"3","key":"4923_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1590\/S1807-59322009000300008","volume":"64","author":"MAM Mimura","year":"2009","unstructured":"Mimura MAM, Hirota SK, Sugaya NN, Sanches JA Jr., Migliari DA. Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial. Clinics. 2009;64(3):193\u20138.","journal-title":"Clinics"},{"issue":"4","key":"4923_CR29","first-page":"88","volume":"2","author":"Y Peng","year":"2015","unstructured":"Peng Y. Montmorillonite dispersed and Sally amine curative effect analysis for the treatment of recurrent oral ulcer. J Gen Stomatol. 2015;2(4):88\u201390.","journal-title":"J Gen Stomatol"},{"key":"4923_CR30","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1086\/515222","volume":"28","author":"VA Ramirez-Amador","year":"1999","unstructured":"Ramirez-Amador VA, Lilly EP, Sergio PDL, Gustavo RT, Martha GG, Samuel PDL, et al. Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial. Clin Infect Dis. 1999;28:892\u20134.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4923_CR31","first-page":"404","volume":"29","author":"FQ Tian","year":"2016","unstructured":"Tian FQ, Tang MQ, Li JH, Huang YC, Li HQ, Zhong QZ, et al. Clinical study of thalidomide treating oral ulcers secondary to acute leukemia. J Clin Hematol. 2016;29(5):404\u20135.","journal-title":"J Clin Hematol"},{"issue":"30","key":"4923_CR32","first-page":"152","volume":"15","author":"PH Wang","year":"2022","unstructured":"Wang PH, Zhong SS, Su RB. The clinical efficacy and safety of thalidomide combined with vitamin B1 and vitamin AD in the treatment of recurrent aphthous ulcer. Chin J Clin Ration Drug Use. 2022;15(30):152\u20134.","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"02","key":"4923_CR33","first-page":"34","volume":"1","author":"HX Xu","year":"2016","unstructured":"Xu HX, Qiu P. The clinical effects of thalidomide combined with total glucosides of Paeony Capsules in the treatment of RAU. Clin Res Pract. 2016;1(02):34.","journal-title":"Clin Res Pract"},{"issue":"2","key":"4923_CR34","first-page":"238","volume":"47","author":"HY Xu","year":"2018","unstructured":"Xu HY, Jiao HM, Guo YL, Li F. The clinical effects of low dose thalidomide combined with multivitamin and minerals tablet for treating recurrent aphthous ulcer. Shaanxi Med J. 2018;47(2):238\u201340.","journal-title":"Shaanxi Med J"},{"issue":"06","key":"4923_CR35","first-page":"108","volume":"29","author":"JC Xu","year":"2017","unstructured":"Xu JC, Chen ZL. Clinical observation of thalidomide combined with total glucosides of Paeony Capsules in the treatment of recurrent aphthous ulcer. Strait Pharm J. 2017;29(06):108\u201310.","journal-title":"Strait Pharm J"},{"issue":"12","key":"4923_CR36","first-page":"127","volume":"31","author":"Q Xu","year":"2019","unstructured":"Xu Q. Clinical observation of thalidomide in the treatment of recurrent aphthous ulcer. Strait Pharm J. 2019;31(12):127\u20139.","journal-title":"Strait Pharm J"},{"issue":"20","key":"4923_CR37","first-page":"153","volume":"31","author":"Q Xu","year":"2021","unstructured":"Xu Q, Zhou L. Effect of Thalidomide combined with cimetidine on the treatment of recurrent oral Ulcer. Shenzhen Vintegr Tradit Chin West Med. 2021;31(20):153\u20135.","journal-title":"Shenzhen Vintegr Tradit Chin West Med"},{"key":"4923_CR38","first-page":"1","volume":"00","author":"QX Zeng","year":"2019","unstructured":"Zeng QX, Shi XK, Yang J, Yang M, Zhao W, Zhao XY, et al. The efficacy and safety of thalidomide on the recurrence interval of continuous recurrent aphthous ulceration: a randomized controlled clinical trial. J Oral Pathol Med. 2019;00:1\u20138.","journal-title":"J Oral Pathol Med"},{"issue":"09","key":"4923_CR39","first-page":"997","volume":"32","author":"J Zhang","year":"2010","unstructured":"Zhang J, Ma M, Zhu LH. Short-term effects of thalidomide in the treatment of recurrent aphthous ulcer. J Ningxia Med Univ. 2010;32(09):997\u20139.","journal-title":"J Ningxia Med Univ"},{"issue":"10","key":"4923_CR40","first-page":"71","volume":"54","author":"JJ Zong","year":"2014","unstructured":"Zong JJ, Lin L, Su S. Effect of thalidomide in the treatment of intractable recurrent aphthous ulcer. J Nanchang Univ(Med Sci). 2014;54(10):71\u20132.","journal-title":"J Nanchang Univ(Med Sci)"},{"issue":"8","key":"4923_CR41","first-page":"1534","volume":"23","author":"H Zhou","year":"2011","unstructured":"Zhou H, Huang FY. The clinical efficacy of thalidomide for recurrent oral aphthous ulcers. Med J West China. 2011;23(8):1534\u20137.","journal-title":"Med J West China"},{"issue":"06","key":"4923_CR42","first-page":"376","volume":"31","author":"ZQ Zhong","year":"2011","unstructured":"Zhong ZQ, Cai ZX. Clinical study of thalidomide combined with prednisone in the treatment of major aphthous ulcer. Stomatol. 2011;31(06):376\u20138.","journal-title":"Stomatol"},{"issue":"3","key":"4923_CR43","first-page":"26","volume":"10","author":"NR Edgar","year":"2017","unstructured":"Edgar NR, Saleh D, Miller RA. Recurrent aphthous stomatitis: a review. J Clin Aesthet Dermatol. 2017;10(3):26\u201336.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"11","key":"4923_CR44","first-page":"e1109","volume":"10","author":"A Dhopte","year":"2018","unstructured":"Dhopte A, Naidu G, Singh-Makkad R, Nagi R, Bagde H, Jain S. Psychometric analysis of stress, anxiety and depression in patients with recurrent aphthous Stomatitis-A cross-sectional survey based study. J Clin Exp Dent. 2018;10(11):e1109\u201314.","journal-title":"J Clin Exp Dent"},{"issue":"6","key":"4923_CR45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1080\/09546634.2017.1422079","volume":"29","author":"SK Saikaly","year":"2018","unstructured":"Saikaly SK, Saikaly TS, Saikaly LE. Recurrent aphthous ulceration: a review of potential causes and novel treatments. J Dermatolog Treat. 2018;29(6):542\u201352.","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"4923_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.imlet.2005.01.002","volume":"99","author":"N Lewkowicz","year":"2005","unstructured":"Lewkowicz N, Lewkowicz P, Banasik M, Kurnatowska A, Tch\u00f3rzewski H. Predominance of type cytokines and decreased number of CD4(+)CD25(+\u2009high) T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations. Immunol Lett. 2005;99(1):57\u201362.","journal-title":"Immunol Lett"},{"issue":"3","key":"4923_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.0904-2512.2004.00089.x","volume":"33","author":"RC Borra","year":"2004","unstructured":"Borra RC, Andrade PM, Silva ID, Morgun A, Weckx LL, Smirnova AS, et al. The Th1\/Th2 immune-type response of the recurrent aphthous ulceration analyzed by cDNA microarray. J Oral Pathol Med. 2004;33(3):140\u20136.","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"4923_CR48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00005-011-0134-1","volume":"59","author":"N Lewkowicz","year":"2011","unstructured":"Lewkowicz N, Kur B, Kurnatowska A, Tchorzewski H, Lewkowicz P. Expression of Th1\/Th2\/Th3\/Th17-Related genes in recurrent aphthous ulcers. Arch Immunol Ther Exp. 2011;59(5):399\u2013406.","journal-title":"Arch Immunol Ther Exp"},{"issue":"1","key":"4923_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.15171\/joddd.2018.007","volume":"12","author":"K Chaudhuri","year":"2018","unstructured":"Chaudhuri K, Nair KK, Ashok L. Salivary levels of TNF-\u03b1 in patients with recurrent aphthous stomatitis: a cross-sectional study. J Dent Res Dent Clin Dent Prospects. 2018;12(1):45\u20138.","journal-title":"J Dent Res Dent Clin Dent Prospects"},{"key":"4923_CR50","doi-asserted-by":"crossref","unstructured":"Surboyo MDC, Boedi RM, Hariyani N, Santosh ABR, Manuaba IBPP, Cecilia PH, et al. The expression of TNF-\u03b1 in recurrent aphthous stomatitis: a systematic review and meta-analysis. Cytokine. 2022 sep;157:155946.","DOI":"10.1016\/j.cyto.2022.155946"},{"issue":"1","key":"4923_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.imlet.2005.01.002","volume":"99","author":"N Lewkowicza","year":"2005","unstructured":"Lewkowicza N, Lewkowiczb P, Banasikb M, Kurnatowska A, Tchorzewski H. Predominance of type 1 cytokines and decreased number of CD4\u2009+\u2009CD25\u2009+\u2009high T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations. Immunol Lett. 2005;99(1):57\u201362.","journal-title":"Immunol Lett"},{"issue":"2","key":"4923_CR52","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S1016-8478(23)13028-7","volume":"17","author":"YS Kim","year":"2004","unstructured":"Kim YS, Kim JS, Jung HC, Song IS. The effects of thalidomide on NF-kB activity and TNF-\u03b1 production stimulated with lipopolysaccharide in a human colonic epithelial cell line. Mol Cells. 2004;17(2):210\u20136.","journal-title":"Mol Cells"},{"issue":"1","key":"4923_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/1753425908099317","volume":"15","author":"AS Noman","year":"2009","unstructured":"Noman AS, Koide N, Hassan F, I-E-Khuda I, Dagvadorj J, Tumurkhuu G, et al. Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-\u03b1 production via down-regulation of MyD88 expression. Innate Immun. 2009;15(1):33\u201341.","journal-title":"Innate Immun"},{"key":"4923_CR54","doi-asserted-by":"crossref","unstructured":"Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor \u03b1 by enhancing mRNA degradation. J Exp Med. 1993 jun;177(6):1675\u201380.","DOI":"10.1084\/jem.177.6.1675"},{"key":"4923_CR55","doi-asserted-by":"crossref","unstructured":"Brocklehurst P, Tickle M, Glenny AM, Lewis MA, Pemberton MN, Taylor J, et al. Systemic interventions for recurrent aphthous stomatitis (mouth ulcers). Cochrane Database Syst Rev. 2012 Sep;12(9):CD005411.","DOI":"10.1002\/14651858.CD005411.pub2"},{"issue":"6","key":"4923_CR56","doi-asserted-by":"publisher","first-page":"e15500","DOI":"10.1111\/dth.15500","volume":"35","author":"CB Lau","year":"2022","unstructured":"Lau CB, Smith GP. Recurrent aphthous stomatitis: a comprehensive review and recommendations on therapeutic options. Dermatol Ther. 2022;35(6):e15500.","journal-title":"Dermatol Ther"},{"issue":"2","key":"4923_CR57","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00784-024-05531-7","volume":"28","author":"W Wei","year":"2024","unstructured":"Wei W, Deng YW, Wang YF, Yao H, Du GH, Tang GY. Dynamic salivary cytokine profile of recurrent aphthous stomatitis patients in thalidomide maintenance treatment. Clin Oral Investig. 2024;28(2):140.","journal-title":"Clin Oral Investig"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04923-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-024-04923-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04923-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T12:01:55Z","timestamp":1727524915000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-024-04923-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4923"],"URL":"https:\/\/doi.org\/10.1186\/s12903-024-04923-1","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1149"}}